About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

New Biomarker To Accurately Predict The Effectiveness Of Drug That Treats Depression

by Aruna on September 14, 2009 at 9:31 AM
Font : A-A+

New Biomarker To Accurately Predict The Effectiveness Of Drug That Treats Depression

University of California scientists have identified a biomarker that can help accurately predict whether a particular drug will be effective in treating major depression.

During the study, the researchers measured changes in brain-wave patterns using quantitative electroencephalography (QEEG), a non-invasive, computerized measurement that recognizes specific alterations in brain-wave activity.

Advertisement

These changes precede improvement in mood by many weeks and appear to serve as a biomarker that accurately predicts how effective a given medication will be.

The new non-invasive test would help predict within a week whether a particular drug will be effective.

The added benefit of the biomarker test is that it is painless and fast - about 15 minutes - and only involves the placement of six electrodes around the forehead and on the earlobes.
Advertisement

The researchers recruited a total of 375 people who had been diagnosed with major depressive disorder (MDD) and prescribed the antidepressant escitalopram, commonly known as Lexapro.

Then they examined a biomarker called the antidepressant treatment response (ATR) index - a specific change in brain-wave patterns.

The study showed that the ATR predicted both response and remission with an accuracy rate of 74 percent, much higher than any other method available.

The researchers also found that they could predict whether subjects were more likely to respond to a different antidepressant, bupropion, also known as Wellbutrin XL.

"Until now, other than waiting, there has been no reliable method for predicting whether a medication would lead to a good response or remission," said Dr. Andrew Leuchter, professor of psychiatry at the Semel Institute for Neuroscience and Human Behavior at UCLA and lead author of the study.

"And that wait can be as long as 14 weeks. So these are very exciting findings for the patient suffering from depression," said Leuchter.

The study results appear in the journal Psychiatry Research.

Source: ANI
ARU
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Prevent Hacking of Medical Devices: FDA Sounds Alarm
Black Water: Benefits and Uses
World Hypertension Day 2022 - Measure Blood Pressure Accurately, Control It, Live Longer!
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Adolescence Depression Drug Toxicity Depression Signature Drug Toxicity Stress Relief Through Alternative Medicine Andropause / Male Menopause Pregnancy and Complications 

Most Popular on Medindia

Blood - Sugar Chart Loram (2 mg) (Lorazepam) Noscaphene (Noscapine) How to Reduce School Bag Weight - Simple Tips Iron Intake Calculator Selfie Addiction Calculator Drug Interaction Checker Find a Hospital Turmeric Powder - Health Benefits, Uses & Side Effects Daily Calorie Requirements

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use